FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN

July 2026
Vol-12, Issue-4
Paper ID: 28820
ISSN: 2395-4396
Downloads: 162
Download PDF

Abstract & Details

Research Area
PHARMACY
Keywords
Losartan Chitosan Microspheres Mucoadhesion Sustained release
Abstract
Losartan potassium, a widely used angiotensin II receptor antagonist, was characterized for its physicochemical and formulation properties. The drug appeared as a light yellow, odorless, bitter, amorphous powder with a melting point of 185–186 °C, confirming purity. Solubility studies revealed good solubility in methanol, while partition coefficient analysis yielded log P value of 1.427 ± 0.012, indicating moderate lipophilicity. UV spectrophotometric analysis in 0.1 N HCl showed maximum absorbance at 239 nm, and calibration curve linearity was established with R² = 0.9994. Chitosan based mucoadhesive microspheres of Losartan potassium were prepared using sodium tripolyphosphate (TPP) as a cross linker. Particle size analysis demonstrated microspheres ranging from 165–241 µm, with smaller particles favoring faster release and larger particles enhancing mucoadhesion. Drug entrapment efficiency varied between 57.37–91.82% w/w, decreasing with higher TPP content due to increased drug diffusion during preparation. In vitro wash off tests showed mucoadhesion values between 63–91%, while percentage yield ranged from 64.83–89.73%. SEM analysis confirmed spherical morphology with smooth surfaces in optimized formulations. In vitro drug release studies indicated sustained release profiles, with formulation F 3 achieving nearly complete release (99.83%) at 8 hours. Kinetic modeling revealed that drug release followed Higuchi (R² = 0.996) and Peppas Korsmeyer (R² = 0.995) models, suggesting diffusion controlled release with mucoadhesive retention. Overall, the study demonstrated that chitosan microspheres provide an effective sustained release system for Losartan potassium, potentially improving therapeutic efficacy and patient compliance.

Author Information

# Name Institute / Affiliation
1 Aashi Gupta NRI Institute of Pharmaceutical Sciences

How to Cite

Use the following formats to cite this article in your research.

APA Style
Gupta, Aashi (2026). FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN. International Journal of Advance Research and Innovative Ideas In Education, 12(4), 673-679.
MLA Style
Gupta, Aashi. "FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN." International Journal of Advance Research and Innovative Ideas In Education, vol. 12, no. 4, 2026, pp. 673-679.
IEEE Style
Aashi Gupta, "FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN," International Journal of Advance Research and Innovative Ideas In Education, vol. 12, no. 4, pp. 673-679, 2026.
Vancouver Style
Gupta Aashi. FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN. International Journal of Advance Research and Innovative Ideas In Education. 2026;12(4):673-679.
Harvard Style
Gupta, Aashi (2026) 'FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN', International Journal of Advance Research and Innovative Ideas In Education, 12(4), pp. 673-679.
Chicago Style
Gupta, Aashi. "FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN." International Journal of Advance Research and Innovative Ideas In Education 12, no. 4 (2026): 673-679.
Turabian Style
Gupta, Aashi. "FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN." International Journal of Advance Research and Innovative Ideas In Education 12, no. 4 (2026): 673-679.

Export Citation